51³Ô¹ÏÍø

Tag - takeda

 
Menu
Search
 
July 24, 2026
 

Home Delivery
Subscribe for more access

TAKEDA

Takeda Pharmaceutical is targeting a return on equity of at least 5% over that time, the company's newly appointed Chief Executive Officer Julie Kim said at her first news conference after assuming the top job this week.
BUSINESS / Companies
Jun 26, 2026
Takeda sees return to growth within three years, new CEO says
The company is targeting a return on equity of at least 5% over that time, Julie Kim said at her first news conference after assuming the top job this week.
Takeda Pharmaceutical headquarters in Tokyo. The company said it will "vigorously pursue" an appeal after a U.S. jury on Monday found the company liable for causing about $885 million in damages by delaying a generic version of its constipation drug through an anticompetitive scheme.
BUSINESS / Companies
May 19, 2026
Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury
The verdict is the ?first time ?a jury has found a pharmaceutical company liable in class-action litigation over what is called a ¡°pay-for-delay¡± agreement with generic rivals.
Psoriasis is a chronic autoimmune disorder that causes rashes marked by itchy, scaly rashes and afflicts more than 125 million people worldwide.
51³Ô¹ÏÍø
Dec 18, 2025
Takeda¡¯s psoriasis pill developed with AI assistance succeeds in trials
If approved, zasocitinib would stand out as one of the first drugs discovered with the help of artificial intelligence.
Takeda's dengue vaccine shows seven years of strong protection against infection and hospitalization, marking the longest efficacy reported to date.
BUSINESS / Companies
Nov 4, 2025
Takeda¡¯s dengue vaccine shows long-lasting protection
The results bolster confidence in Takeda¡¯s two-dose regimen, especially as countries grapple with record dengue outbreaks fueled by climate change.
Takeda Pharmaceutical¡¯s experimental narcolepsy drug shows significant improvement in late-stage trials, potentially targeting the root cause of the disorder.
51³Ô¹ÏÍø / Science & Health
Sep 9, 2025
Takeda nears first therapy for root cause of narcolepsy
Patients who took the drug, called oveporexton, for 12 weeks experienced increased daytime alertness and an overall improvement in quality of life.
Capsules of Takeda Pharmaceutical's Prevacid heartburn drug. The company's share price dropped by over 5% on Monday after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs.
BUSINESS / Markets
May 12, 2025
Asian pharma stocks tumble on Trump signal to cut U.S. drug prices
The U.S. president¡¯s social media post put pressure on drug-related stocks on worries their profits will take a hit if they have to reduce prices in the U.S.
Takeda Pharmaceutical's headquarters in Tokyo
BUSINESS / Companies
Jan 30, 2025
Takeda picks first female CEO of centuries-old drugmaker
Julie Kim, 54, has been running Takeda¡¯s U.S. operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval, the company said.
Takeda Pharmaceutical raised its full-year operating profit guidance to ?265 billion from ?225 billion, citing a stronger than expected first-half performance and updated currency assumptions.
BUSINESS
Oct 31, 2024
Japan¡¯s Takeda raises full-year profit forecast amid restructuring
Takeda raised its full-year operating profit guidance to ?265 billion from ?225 billion, citing a stronger than expected first-half performance.
Takeda Pharmaceutical is in talks to make its dengue vaccine available in India.
BUSINESS / Companies
Feb 28, 2024
Takeda in regulatory talks to launch dengue vaccine in India
Takeda¡¯s dengue vaccine is currently available for children and adults in countries like Indonesia, Thailand, Argentina and Brazil.
Medics tend to COVID-19 patients at the intensive care unit of a hospital in Sofia, Bulgaria, in 2022.
51³Ô¹ÏÍø / Science & Health
Oct 7, 2023
Japan-led team identifies how severe COVID-19 cases develop
The research results are expected to facilitate the development of drugs to prevent serious COVID-19 complications.
Japan Times
BUSINESS
Mar 4, 2023
Japanese pharmaceutical firm Takeda lowers price of dengue shot in Brazil and Indonesia
The cost for Qdenga in Indonesia will be about one-third its European price, far lower than many other innovative vaccines, Takeda CEO Christophe Weber said in an interview.
Japan Times
BUSINESS / Companies
Dec 14, 2022
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
Japan Times
51³Ô¹ÏÍø
Sep 2, 2021
Moderna to recall COVID-19 doses in Japan over stainless steel contaminants
The health ministry said particles of stainless steel were found in suspended Moderna COVID-19 vaccines, but it did not expect they would pose an additional health risk.
Japan Times
51³Ô¹ÏÍø / Science & Health
May 23, 2021
Japan clinical trial of COVID-19 plasma therapy highlights slow-moving medical policy
Doctors are gearing up for clinical trials of convalescent plasma therapy, but many overseas hospitals have already moved on to other remedies.
Japan Times
51³Ô¹ÏÍø
Mar 5, 2021
Japan¡¯s Takeda seeks government approval for Moderna COVID-19 vaccine
While awaiting regulatory approval, Takeda plans to start distributing the Moderna vaccine in the first half of this year.
Japan Times
BUSINESS / Companies
Aug 24, 2020
Takeda to sell consumer unit to Blackstone for ?242 billion
Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ?242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.¡¯s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
BUSINESS
Mar 4, 2020
Japan¡¯s largest drugmaker working to develop virus treatment, Dow Jones reports
Takeda Pharmaceutical Co. is developing an experimental therapy for the novel coronavirus with the goal of making it available in 9 to 18 months, the nation¡¯s largest drugmaker said.
Japan Times
BUSINESS / Companies
Feb 20, 2020
As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines
The spread of novel coronavirus infections is starting to make one thing clear: More vaccine investment is needed, the CEO of Asia¡¯s biggest drugmaker said.
Japan Times
51³Ô¹ÏÍø / Science & Health
Nov 7, 2019
Takeda¡¯s dengue vaccine said effective overall in study but with major limitation
Takeda Pharmaceutical Co.¡¯s experimental dengue vaccine was highly effective at preventing the mosquito-borne disease in a late stage study, but it failed to protect against one type of the virus in people with no prior exposure to dengue.
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
A team of researchers said they found a ¡°seed¡± that accelerates the amyloid beta accumulation process in the brain, naming it ¡°Peak 1 amyloid beta,¡± as seen in a mouse's brain.
Indian brothers make manga debut in Japan
Two Indian brothers made their manga debut in Japan with "Kung Fu Kung Fool" ¡ª an action-comedy series that follows the adventures of a notorious thief and a young boy.
Japan weighs regulating Pokemon cards amid trading mania
A Pokemon event is held in Jakarta on July 11
Low-income families in Japan cut food and air conditioning during summer break
Yumiko Watanabe, the chairperson of nonprofit Kidsdoor, explains the results of a survey in Tokyo's Chiyoda Ward on July 1.
Iran strikes on CIA facilities prompt questions about possible Russian role
Iranian drones are displayed in an undisclosed location in Iran, in this handout image obtained on Jan. 13, 2025.U.S. officials have acknowledged that Russia has ?provided targeting ?and other support for Iran in its drone strikes on U.S. targets in the Persian Gulf region.
The sci-fi sensibilities of electronic trio Black Boboi
Black Boboi was formed in 2018 when solo artists Julia Shortreed, Utena Kobayashi and Ermhoi came together under Kobayashi¡¯s newly founded label, Bindividual.
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Okayama-born singer-songwriter Kaze Fujii has carved out a distinctive place in Japanese pop since his major-label debut in 2019.
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
Wes-P has millions of followers and his viral clips made him recognizable out of Japan.
The 180-day locals: Life on Japan¡¯s digital nomad visa
Christopher Flinn works remotely from Tokyo earlier this month. Japan issued 646 digital nomad visas in 2025, but tourism officials are hoping to increase that figure in the coming years, with Japan's relatively cheap cost of living and the weak yen seen as potential draws for young professionals.
Japan reveals hint of new defense spending target in fiscal blueprint
The Self-Defense Forces' Type 16 mobile combat vehicle fires during a joint live-fire drill with U.S. Marines as part of the annual Resolute Dragon exercises in Yufu, Oita Prefecture, on June 28.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo¡¯s Shinjuku Ward.
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯

Longform

For many people, utility poles and power lines have become such a familiar part of Japan¡¯s landscape that they often go unnoticed.
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By Alex K.T. Martin

SUSTAINABLE 51³Ô¹ÏÍø

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER